Recurrent IgA Nephropathy After Kidney Transplantation

Area of Science:

• Nephrology
• Transplantation Immunology
• Glomerular Diseases

Background:

• Immunoglobulin A (IgA) nephropathy is a leading cause of kidney disease globally.
• High rates of IgA nephropathy recurrence post-kidney transplantation pose a significant clinical challenge.
• Understanding recurrence factors is vital for improving long-term transplant outcomes.

Purpose of the Study:

• To evaluate the survival of kidney allografts in patients with IgA nephropathy.
• To determine the impact of IgA recurrence on allograft function and survival.
• To identify risk factors associated with IgA nephropathy recurrence after transplantation.

Main Methods:

• Retrospective analysis of 104 kidney transplant recipients with IgA nephropathy between 1993 and 2014.
• Inclusion of patients who underwent single or multiple allografts.
• Documentation and analysis of IgA recurrence events and associated clinical data.

Main Results:

• IgA nephropathy recurrence was observed in 19% of allografts, with a median time to recurrence of 6.75 years.
• Younger age at transplantation (mean 37.7 years) and living related donors were associated with increased recurrence risk.
• Allograft survival was significantly reduced in patients with recurrence (6.5 years) versus those without (10.4 years).
• At 6 years post-transplant, 52% of the recurrence group experienced allograft failure compared to 10% in the non-recurrence group.

Conclusions:

• Post-transplant IgA nephropathy recurrence is a major contributor to kidney allograft loss.
• Younger recipient age and the use of living related donors are significant risk factors for recurrence.
• Intensified monitoring and timely treatment are essential for managing IgA recurrence and preserving allograft function.